InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross MarginsPRNewsWire • 07/30/25
InMode (INMD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/23/25
InMode to Report Second Quarter 2025 Financial Results and Hold Conference Call on July 30, Expects Q2 Revenue Between $95.4M-$95.5M, Decreases Full Year 2025 Revenue Guidance to be Between $365M-$375MPRNewsWire • 07/10/25
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Resume Share Repurchase ProgramPRNewsWire • 05/09/25
InMode Granted Injunction Against Counterfeit Sales of Morpheus8 Radio Frequency Microneedling Devices and Needle CartridgesPRNewsWire • 05/06/25
Eyes On Park Introduces Revolutionary Envision by InMode System for Advanced Dry Eye Treatment in New York CityNewsfile Corp • 04/28/25
InMode Reports First Quarter 2025 Financial Results; Quarterly Revenue of $77.9 Million Represents 3% Year-Over-Year DecreasePRNewsWire • 04/28/25
InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)Seeking Alpha • 04/03/25
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 RallyZacks Investment Research • 03/26/25
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase ProgramPRNewsWire • 02/04/25
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools ConferencePRNewsWire • 02/03/25